Private Equity Activity Surges in Q2
Despite some market woes, private equity remained bullish in the healthcare market for the second quarter of 2023. Deal volume from PE hit 216 transactions, a significant increase from the 191 announced in the first quarter of 2023, according to data captured in the LevinPro HC platform. The surge in PE activity helped push overall M&A activity to 586 deals in Q2, an 8% jump from volume in the first quarter. The pace of M&A might come as a surprise, considering some of the headwinds in the industry. Labor issues and high-interest rates have persisted throughout the year, and new reimbursement changes have hit the industry, especially some industry giants. Envision Healthcare,... Read More »
Atlas Clinical Research Acquires Suburban Research Associates
Atlas Clinical Research announced the addition of Suburban Research Associates to its site network, marking the second clinical research site partnership for the platform. Atlas previously formed a strategic partnership with Rochester Clinical Research in April 2023. Specializing in psychiatric research, Suburban will seek to expand its research impact and leverage Atlas’ site connectivity to better serve trial patients. According to data captured in the LevinPro HC database, this transaction represents the 14th clinical trials acquisition of 2023. Founded in 1999 by Dr. Shivkumar Hatti, Suburban Research Associates is a clinical research site conducting psychiatric research from its... Read More »
PE-Backed Vantage Surgical Solutions Acquires Ophthalmic Surgical Solutions
Vantage Surgical Solutions, a portfolio company of private equity firm Pharos Capital Group, announced its acquisition of Ophthalmic Surgical Solutions (OSS). According to data captured in the LevinPro HC database, this transaction represents the 68th Medical Devices transaction of 2023. Founded in 2015, OSS is a Lecompton, Kansas-based company specializing in ophthalmic surgical equipment and services. Vantage Surgical Solutions is a leading provider of mobilized surgical solutions. Vantage has been equipping facilities for specialty surgical services since 1991, with customers in 23 states. The company currently delivers cataract surgery equipment, IOLs, instrumentation, disposables,... Read More »
Fortis Life Sciences Acquires International Point of Care
Fortis Life Sciences, backed by Boston-based private equity firm Summit Partners, has acquired Toronto-based International Point of Care (IPOC). IPOC specializes in developing and manufacturing diagnostic components. IPOC serves many of the leading global diagnostic companies enabling the commercialization of new immunodiagnostic and molecular diagnostic technologies. Fortis Life Sciences partners with diagnostics and life sciences companies to custom-design, validate and manufacture proprietary solutions to solve their most difficult development problems. Fortis serves a global customer base and has offices worldwide including four R&D sites and three GMP and ISO 13485 compliant... Read More »
Thermo Fisher Scientific to Acquire CorEvitas from Audax Private Equity
Thermo Fisher Scientific Inc. announced that it entered into a definitive agreement to acquire CorEvitas, LLC from Audax Private Equity, for $912.5 million. The transaction is expected to be completed by the end of 2023. CorEvitas, based in Waltham, Massachusetts, with operations focused in the United States, provides regulatory-grade, real-world evidence solutions to pharmaceutical and biotechnology companies with objective data and clinical insights to improve patient care and clinical outcomes. CorEvitas manages 12 registries, including nine autoimmune and inflammatory syndicated registries. Its multi-therapeutic data intelligence platform builds and scales multiple clinical registries... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
